NaviFUS (ROCO:6872) Cash Flow from Others : NT$-0.26 Mil (TTM As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is NaviFUS Cash Flow from Others?

NaviFUS's cash flow from others for the six months ended in Dec. 2023 was NT$3.04 Mil. Its cash flow from others for the trailing twelve months (TTM) ended in Dec. 2023 was NT$-0.26 Mil.

NaviFUS Cash Flow from Others Historical Data

The historical data trend for NaviFUS's Cash Flow from Others can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NaviFUS Cash Flow from Others Chart

NaviFUS Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash Flow from Others

Get a 7-Day Free Trial

3.24

-1.32

3.51

0.16

-0.25

NaviFUS Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Cash Flow from Others	Get a 7-Day Free Trial					2.59	-0.27	0.43	-3.30	3.04

NaviFUS Cash Flow from Others Calculation

Cash Flow from Others for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$-0.26 Mil.

NaviFUS Cash Flow from Others Related Terms

Thank you for viewing the detailed overview of NaviFUS's Cash Flow from Others provided by GuruFocus.com. Please click on the following links to see related term pages.

NaviFUS (ROCO:6872) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NaviFUS Corp (ROCO:6872) » Definitions » Cash Flow from Others

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.246, Sec 3, Chengde Road, 12th Floor, Datong District, Taipei City, TWN, 103

Website

https://www.navifus.com

NaviFUS Corp is a Biotech company providing novel platform solutions for crossing the blood-brain barrier (BBB) for enhanced oncology drug delivery. Its product, the NaviFUS System, is designed to utilize non-invasive ultrasound energy to enable transient and safe enhancement of BBB permeability to facilitate the transport of small or large molecular CNS drugs to target tumor tissue at high precision for better treatment outcomes. Its vision is to cater to CNS disease patients locally and globally by bringing therapeutic ultrasound technology to clinical use.

NaviFUS (ROCO:6872) Headlines

No Headlines